No items currently found in
Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes
If left undiagnosed or not properly managed, diabetes can cause serious health complications. 1 The HbA1c test ... life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading ...
Verinata Health Publishes Clinical Laboratory Performance Data for verifiĀ® Prenatal Test
Test Results in a Clinical Laboratory Setting In the study published online today ... Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and ...
Illumina Inc. Presents at UBS Global Healthcare Conference, May-20-2013 11:30 AM
I'm the life sciences analyst at UBS. I'm going to ahead and introduce ... As the tagline says here on the chart, we are the worldwide leader in genomic analysis. 2012, we had revenue of $1.15 billion, which was a growth rate of 9% year-over ...
OPKO Announces First Quarter 2013 Operating and Financial Highlights
"We are pleased with the advances of our operating businesses, as well as the progress made in the development of our CTAP101 Capsules and 4Kscore prostate diagnostic test. Our solid ... company and the only life science company listed on ...
Luminex's CEO Presents at UBS Global Healthcare Conference (Transcript)
This assay in the United States can detect 11 different gastrointestinal pathogens which is extremely important from a clinical perspective because the symptoms that physicians are dealing with are often the same whether the patient has salmonella or ...
Opko Updates on First Quarter 2013 Operating and Financial Highlights [Manufacturing Close - Up]
Opko Health, Inc., a multi-national biopharmaceutical and diagnostics company, reported operating and financial highlights for the first quarter of 2013. "Consistent with our growth strategy, progress across most business fronts accelerated ...